Self-priming effect of LH-RH on pituitary gonadotropins in hyperprolactinemic women.
To investigate how various concentrations of serum prolactin (PRL) influence the priming effect of luteinizing hormone releasing hormone (LH-RH) on the pituitary gland, 24 women with various blood PRL concentrations received intravenous injections of 100 micrograms of synthetic LH-RH twice at an interval of 60 minutes and their serum LH and follicle-stimulating hormone (FSH) were measured and analysed. In the follicular phase with a normal PRL concentration (PRL less than 20 ng/ml, n = 6), marked first peaks of the two hormones following the first LH-RH stimulation and enhanced second peaks after the second LH-RH administration were observed, indicating a typical priming effect of LH-RH on gonadotropins, though the second response of FSH was more moderate than that of LH. In hyperprolactinemia, in which the serum PRL concentration was higher than 70 ng/ml (n = 13), the basal concentration of gonadotropins was not significantly changed but the priming effect of LH-RH on LH and FSH was significantly decreased (p less than 0.01). No marked second peaks of LH and FSH were observed, suggesting an inhibitory effect of hyperprolactinemia on the second release of LH and FSH. In contrast, this effect was restored in a group of women whose serum PRL concentration was between 30 and 50 ng/ml (n = 5). Furthermore, enhanced second peaks of both LH and FSH were noted after successful bromocriptine therapy reduced hyperprolactinemia (PRL greater than 70 ng/ml) to less than 25 ng/ml (n = 5).(ABSTRACT TRUNCATED AT 250 WORDS)
Makino
T
T
Department of Obstetrics and Gynecology School of Medicine, Keio University, Tokyo, Japan.
Takahashi
M
M
Fukuoka
K
K
Seki
T
T
Iizuka
R
R
D000328:Adult; D004334:Drug Administration Schedule; D005260:Female; D007987:Gonadotropin-Releasing Hormone / Q000008:administration & dosage / Q000494:pharmacology* / Q000502:physiology; D006065:Gonadotropins, Pituitary / Q000502:physiology*; D006801:Humans; D006966:Hyperprolactinemia / Q000503:physiopathology*; D007031:Hypothalamus / Q000503:physiopathology; D010902:Pituitary Gland / Q000187:drug effects
D006065:Gonadotropins, Pituitary; D007987:Gonadotropin-Releasing Hormone